Dana dhuwit perusahaan Avenue Therapeutics Inc (ATXI)

Avenue Therapeutics Inc - logo grafis emiten ATXI

Avenue Therapeutics (ATXI) develops advanced therapies for acute brain injuries by investing in rapid molecular compounds. Changes in cash and cash equivalents visualize this process, with 0.00 representing the latest level. Geopolitical barriers and sanctions are hindering the international certification of drugs. However, the sector's independence from macroeconomics and stable demand make the asset a reliable defensive tool.

ATXI - Cadangan dhuwit perusahaan Avenue Therapeutics Inc ing rentang 04.07.2022 - 29.03.2025

Rincian metrik komprehensif lan analitis Avenue Therapeutics, Inc. (ATXI)

Analisis dhasar perusahaan:avenuetx.com
Sampel barang avenuetx.com

Avenue Therapeutics specializes in developing drugs for the therapy of neurological pathologies amidst fierce patent competition. By analyzing changes in cash levels, investors assess liquidity through the lens of daily price action to eliminate data gaps. An increase in reserves can be interpreted both as a survival guarantee and as an inefficient use of capital. In the binary business of biopharmaceuticals, this cushion is critical for passing FDA trials. This metric determines the financial stability of Avenue Therapeutics until the moment of product commercialization.

Pesaing Avenue Therapeutics

Volume dana dhuwit perusahaan BIIB|Dana dhuwit perusahaan NBIX (Neurocrine Biosciences)|Dana dhuwit perusahaan Regencell Bioscience Ltd RGC|AXSM (Axsome Therapeutics, Inc.) - Total volume dana dhuwit perusahaan|ACADIA Corp - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Xenon Pharmaceuticals|VKTX (Viking Therapeutics Corp) - Dhuwit awis perusahaan|Supernus Pharmaceuticals (SUPN) - Volume dana dhuwit perusahaan|CPRX (Catalyst Pharma) - Volume dana dhuwit perusahaan|DNLI (Denali Therapeutics Inc.) - Gunggung dana dhuwit perusahaan|Volume dana dhuwit perusahaan HRMY|Biohaven Corp - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan AMLX (amylyx.com)|Aset likuid perusahaan Trevi Therapeutics, Inc. (TRVI)|Praxis Corp - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Anavex|CBLL (CeriBell Inc) - Dhuwit awis perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan PRTA|Dana dhuwit perusahaan Alector Inc.|Cadangan dhuwit perusahaan Annexon, Inc. ANNX|Dana dhuwit perusahaan Omeros Corp (OMER)|NGNE (Neurogene Inc) - Sisa dhuwit perusahaan|Dana dhuwit perusahaan AC Immune Inc ACIU|Posisi dhuwit perusahaan Voyager Corp|Neumora Corp - Volume dana dhuwit perusahaan|scilexholding.com (SCLX) - Dhuwit awis perusahaan|Tevogen Bio Holdings, Inc. (TVGN) - Dana dhuwit perusahaan|Alpha Cognition Corp (ACOG) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan CGTX|Dhuwit awis lan setara dhuwit awis perusahaan IKT (Inhibikase)|Volume dana dhuwit perusahaan SAVA|Assertio - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan COYA (Coya Therapeutics)|Volume dana dhuwit perusahaan Vistagen Therapeutics VTGN|OVID: Dhuwit awis perusahaan|ABOS - Volume dana dhuwit perusahaan|CRVO: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Alterity Therapeutics Ltd. (ATHE)|Dana dhuwit perusahaan Clene Inc.|pepgen.com (PEPG) - Aset likuid perusahaan|Dhuwit awis perusahaan JUNS (jupiterneurosciences.com)|Dana dhuwit perusahaan RLMD (Relmada Corp)|Annovis Bio, Inc. - Dhuwit awis perusahaan|Posisi dhuwit perusahaan Grace Therapeutics, Inc.|Firefly Neuroscience, Inc - Volume dana dhuwit perusahaan|KLTO - Volume dana dhuwit perusahaan|NRSN (NeuroSense Therapeutics Ltd.) - Dhuwit awis perusahaan|RVPH - Aset likuid perusahaan|Dana dhuwit perusahaan MetaVia|Dhuwit awis lan setara dhuwit awis perusahaan NRXS (neuraxis.com)|Dana dhuwit perusahaan Helius Medical Technologies (HSDT)|PASG (Passage Bio) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan NEUP (Neuphoria Therapeutics)|Sisa dhuwit perusahaan NERV|ATHA - Dana dhuwit perusahaan|Total volume dana dhuwit perusahaan ADXN|ALZN (Alzamend Neuro) - Dhuwit awis perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan CYCN|PTIX (Protagenic Therapeutics, Inc.) - Volume dana dhuwit perusahaan|KTTA: Sisa dhuwit perusahaan|Dana dhuwit perusahaan Cortigent Medical (CRGT)|Dana dhuwit perusahaan BCLI (Brainstorm Cell)|Volume dana dhuwit perusahaan CARA (Cara Therapeutics Inc)|Sisa dhuwit perusahaan CHRO|Eliem Therapeutics Inc. - Volume dana dhuwit perusahaan|ITCI - Volume dana dhuwit perusahaan|Longboard Pharma (LBPH) - Dana dhuwit perusahaan|Dhuwit awis perusahaan Marinus Pharmaceuticals|Dana dhuwit perusahaan NKGen|Volume dana dhuwit perusahaan NeuroBo Pharmaceuticals, Inc.|Volume dana dhuwit perusahaan SAGE|Synaptogenix, Inc - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan Trevena TRVN|Posisi dhuwit perusahaan Vigil Neuroscience|Anew Medical Inc. - Volume dana dhuwit perusahaan|Aset likuid perusahaan Cerevel Therapeutics, Inc. CERE